SHARE
COPY LINK
PRESENTED BY AXA

Mental health: what are the warning signs international residents should look out for?

Even today, mental health issues are too often subject to stigma and taboos. If you’re living or working abroad, you can face huge challenges and not know where to turn for help or support.

Mental health: what are the warning signs international residents should look out for?
Photo: Getty Images

The Covid-19 pandemic has shone a light on some issues of stress, loneliness and depression. But it should not need a global crisis to increase awareness of and create more open discussion about such a serious issue.

The Local has partnered with AXA – Global Healthcare to examine how and why people living international lives should pay special attention to their mental health.

Moving abroad to work? Find out more about AXA – Global Healthcare’s international health insurance options

Trouble adjusting? You’re not alone

Following a career overseas as an international worker can be exciting and challenging in equal measure. Multinational workforces are now the norm in most global major cities and businesses increasingly view diversity as one of their biggest strengths.

Yet many people struggle to adapt as they face up to dealing with culture shock, new ways of working, a different language, and being distant from friends and family. If this sounds familiar, you’re far from alone.

One in five employees surveyed in AXA’s 2020 World of Work research¹ experienced mind health difficulties while working away from home. Half said that the biggest impact on their mental health came at the start of their time in a new location.

Mental health challenges faced when working away from home can have a number of consequences, such as work performance issues, increased risk of illness and organizational difficulties. In some cases, this can lead to assignments ending early and missed experiences. 

Working away from home always comes with its own series of challenges, without mental health difficulties compounding the situation. This is why it’s so important not only to monitor how you’re doing, but also be able to have meaningful conversations with your manager if you’re struggling.

This is not always possible. Around two thirds (64 percent) of employees surveyed agreed that their employer could do more to support their mental health and 50 percent said that their employer only offers support in response to a crisis¹. In taking a new position overseas, it’s worthwhile asking what support a potential employer can offer you.

With AXA’s Mind Health service, you can speak to a psychologist from wherever you are in the world².

Know the warning signs

While everybody responds to stress and difficulties differently, there are common signs that you may be struggling. If you experience a number of the following over the space of a few weeks, it’s worth contacting a health professional to talk.

Reflect, reevaluate, recharge

It could be worth monitoring your mood and observing whether there is a discernible dip, or an increase in negative feelings.

There are a number of free apps and online tools, including AXA’s Low Mood and Anxiety Quizzes, that can allow you to track your daily mood over the space of weeks or months. They can also allow you to identify triggers for sudden dips in mood, or anxiety.

If the results of your mood tracking raises concerns about your mental health, your insurer will often have support services to help you rest, recharge and heal. 

AXA, a global leader in health insurance, has multiple levels of cover to suit you at different stages of your life, giving you access to local healthcare professionals and facilities. If you struggle with the local language, and/or prefer to speak to a doctor from where you are, their Virtual Doctor service can do everything from consultations, to prescriptions and referrals to specialists if you need further treatment³. 

Mental health is as important as our physical health, and it deserves the same attention. If you’re in an environment that may lead to increased stress and mental health challenges, it’s worth considering how you can take the best care of yourself and make the most of your opportunities abroad.

Understand the range of insurance options that can help you take care of your health with AXA

1. Research conducted in April 2020 by Savanta. A total of 543 HR decision makers (108 in North America, 105 in the UK, 51 in France, 54 in Germany, 111 in China, 55 in Hong Kong and 59 in Singapore) and 568 non-native assignees (107 in North America, 113 in the UK, 57 in France, 57 in Germany, 116 in China, 60 in Hong Kong and 65 in Singapore) were surveyed.

2. The service provides you with up to 6 sessions with a psychologist, per mind health concern, per policy year.

3.  Appointments are subject to availability. You do not need to pay or claim for a consultation but you will be charged for the cost of the initial phone call when using the call back service. Telephone appointments are available 24/7/365 and call-backs are typically within 24 hours. Video appointments are available between 08.00 and 00.00 UK time, Monday to Friday. Video appointments in German are available between 08:00-20:00 CET, Monday to Friday. Prescriptions are available if medically necessary and are subject to your location.

This article was produced by The Local Creative Studio and presented by AXA.

AXA Global Healthcare (EU) Limited. Registered in Ireland number 630468. Registered Office: Wolfe Tone House, Wolfe Tone Street, Dublin 1. AXA Global Healthcare (EU) Limited is regulated by the Central Bank of Ireland.

AXA Global Healthcare (UK) Limited. Registered in England (No. 03039521). Registered Office: 20 Gracechurch Street, London, EC3V 0BG, United Kingdom. AXA Global Healthcare (UK) Limited is authorised and regulated in the UK by the Financial Conduct Authority.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

‘Possible link’ between AstraZeneca vaccine and rare blood clots, EMA concludes

The European Medicines Agency has come to the conclusion that the unusual blood clots suffered by numerous people around Europe should be considered as rare side effects of AstraZeneca's Covid-19 vaccine, but that overall the benefits of the jab outweigh the risk.

'Possible link' between AstraZeneca vaccine and rare blood clots, EMA concludes
Photo by Tiziana FABI / AFP

A statement published online read: “The EMA’s safety committee has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of the COVID-19 AstraZeneca vaccine.”

The EMA added however that the benefits of the vaccine outweigh the risks.

While millions of doses of the vaccine developed with Oxford University have been administered, small numbers of people have developed deadly blood clots, which prompted countries including the European Union’s three largest nations – Germany, France and Italy – to temporarily suspend injections pending the EMA investigation.

In March the EMA said the vaccine was “safe and effective” in protecting people against Covid-19 but that it couldn’t rule out a link to blood clots, and that more investigations were needed.

On Wednesday the EMA said the AstraZeneca vaccine should continue to be used for all age groups but that people should be told of the possible rare side effects. The announcement came as the UK’s own drugs regulator said the AZ vaccine should now only be given to over 30s.

The EMA said it was “reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within two weeks of vaccination.”

One plausible explanation for the combination of blood clots and low blood platelets is an immune response, the EMA said but that it had not identified any clear risk factors for causing the clots including age or gender.

So far, most of the cases reported have occurred in women under 60 years of age within two weeks of vaccination. 

The EMA advised that people who have received the vaccine should seek medical assistance immediately if they develop symptoms of this combination of blood clots and low blood platelets.

Symptoms include shortness of breath, chest pain, swelling in legs, abdominal pain, severe headaches, blurred vision and tiny blood spots under the skin at the sight of the injection.

The EMA committee carried out an in-depth review of 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of 22 March 2021, 18 of which were fatal

The agency concluded: “COVID-19 is associated with a risk of hospitalisation and death. The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.”

Germany, France and Italy have all restarted AstraZeneca vaccines, but in the case of France and Germany with extra guidelines on the age of patients it should be used for. France is currently not administering the AstraZeneca vaccine to under 55s or over 75s.

SHOW COMMENTS